India to Kenya: Artemether Export Trade Route
India has recorded 695 verified shipments of Artemether exported to Kenya, representing a combined trade value of $652.7M USD. This corridor is served by 84 active Indian exporters, with an average shipment value of $939.2K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 90% of total export value with 22 shipments worth $590.7M USD. On the buying side, KENYA MEDICAL SUPPLIES AUTHORITY (K is the largest importer in Kenya with $588.0M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, INNOVA CAPTAB LIMITED, AFROWAY PHARMA — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Artemether corridor is one of India's established pharmaceutical export routes, with 695 shipments documented worth a combined $652.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's artemether manufacturing sector.
Across 84 active suppliers, the average shipment value stands at $939.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #12 among India's top artemether export destinations globally.
On the import side, key buyers of Indian artemether in Kenya include KENYA MEDICAL SUPPLIES AUTHORITY (K, TO THE ORDER OF, THE MANAGER, and 134 others. KENYA MEDICAL SUPPLIES AUTHORITY (K is the single largest importer with 8 shipments valued at $588.0M USD.
